# FDA recall D-1340-2014

> **Schindele Enterprises dba Midwest Wholesale** · Class I · drug recall initiated 2014-01-09.

## Product

XZEN PLATINUM, 750 mg, Distributed by: XZEN, Los Angeles, CA.

## Reason for recall

Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

## Distribution

Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI

## Key facts

- **Recall number:** D-1340-2014
- **Recalling firm:** Schindele Enterprises dba Midwest Wholesale
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-01-09
- **Report date:** 2014-05-28
- **Termination date:** 2015-02-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Nixa, MO, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1340-2014

## Citation

> AI Analytics. FDA recall D-1340-2014. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-1340-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*